Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.
AUTOR(ES)
Nepom, G T
RESUMO
Anti-idiotypic antibodies are described that were raised against murine monoclonal antibody 8.2, an antibody specific for a human melanoma-associated cell surface marker called p97. The 8.2 idiotopes recognized by this anti-idiotypic antiserum are binding site-associated and are shared by other monoclonal anti-p97 antibodies with the same specificity as antibody 8.2. Mice immunized with the anti-idiotype demonstrate delayed-type hypersensitivity reactions when challenged with melanoma (p97-positive) tumor cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=345172Documentos Relacionados
- Possible role of anti-idiotypic antibodies in the induction of tumor immunity.
- Suppression of tumor rejection by autologous anti-idiotypic immunity
- Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies.
- Induction of immune response to influenza virus with anti-idiotypic antibodies.
- Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies.
